Latest / Ageless Future / Exploring the Next Generation of Metabolic Health Innovations
Transcript
- 0:00Speaker 1: We're looking at some of the new era of metabolic medicine.
- 0:05Speaker 1: The two big ones we're going to be comparing.
- 0:07Speaker 2: Is or full forglapron it sounds like a.
- 0:10Speaker 1: Transformer or like an alien, or forglaprone versus red a
- 0:17Speaker 1: true tide.
- 0:17Speaker 2: A lot of people are talking about this.
- 0:19Speaker 1: It's an oral gop one, no injections required, and I
- 0:24Speaker 1: think that's really attractive for a lot of people.
- 0:27Speaker 2: I'm sure you guys would would agree.
- 0:29Speaker 1: Sometimes in doing the daily or weekly injections aren't the
- 0:33Speaker 1: most comfortable things. There's no fasting window before you take
- 0:37Speaker 1: the medication. The thought is is it makes it easier
- 0:42Speaker 1: for a patient compliance you take the capsule. That's a
- 0:45Speaker 1: lot easier than doing an injection. Welcome everybody to the
- 1:03Speaker 1: Ageless Future podcast. This is your host today, Kate Archibald.
- 1:07Speaker 1: We're going to be diving in to interesting topic looking
- 1:12Speaker 1: at some of the new sides of weight loss and
- 1:17Speaker 1: metabolic activation. So much research and new new things from
- 1:22Speaker 1: GLP to other drugs and medications on the market. We
- 1:27Speaker 1: thought it would be an interesting podcast to just kind
- 1:30Speaker 1: of showcase some of that new research and what we're
- 1:34Speaker 1: looking at and maybe what you could look at and consider.
- 1:38Speaker 2: So, like I said, we're.
- 1:40Speaker 1: Looking at some of the new era of metabolic medicine.
- 1:45Speaker 1: The two big ones we're going to be comparing is
- 1:48Speaker 1: or full for glapron sounds like a transformer or like
- 1:53Speaker 1: an alien, or forglapron versus red a true tide. And
- 1:59Speaker 1: maybe you've you've probably heard us talk a little bit
- 2:02Speaker 1: about retitrue tide before and maybe even or for lapron
- 2:06Speaker 1: it is a mouthful, but I think they both are
- 2:11Speaker 1: currently going through some of the clinical trials and research
- 2:16Speaker 1: phases and it's super fascinating to see what's evolved.
- 2:23Speaker 2: And some of those findings.
- 2:25Speaker 1: So I'm going to talk to you about those today
- 2:28Speaker 1: and then we'll give again some ways you can activate
- 2:32Speaker 1: your your metabolic recharge metabolic reset for yourself.
- 2:38Speaker 2: And so hopefully you'll have a good time here.
- 2:41Speaker 1: So talking or full, I still have said it about
- 2:45Speaker 1: thirty times even before I hopped on here. It's like
- 2:48Speaker 1: or for glapron or foregloon, but it's a mouthful or
- 2:52Speaker 1: floor Glapron versus retitrue tide. So you have a once
- 2:56Speaker 1: daily pill now delivers GLP one benefit without use of injections.
- 3:02Speaker 1: So that sort of for for glopron. It's a capsule
- 3:06Speaker 1: based UH interacts similar to the g LP and so
- 3:10Speaker 1: this is like a next gen peptide that can you know,
- 3:15Speaker 1: has the potential to push some serious metabolic results. And
- 3:20Speaker 1: it's it's been pretty crazy seeing how you know, first
- 3:25Speaker 1: on the scene was semiglue tide or odic as most
- 3:28Speaker 1: people know it as, and then next was Manjaro turzepetide,
- 3:32Speaker 1: and there's been a lot of kind of different different
- 3:35Speaker 1: iterations of that, and now the injectable side is red
- 3:39Speaker 1: a true tide, and then they've come up with this
- 3:43Speaker 1: compound or for glapron as a capsule based with similar effects.
- 3:49Speaker 1: And so you know, the the real question is is
- 3:52Speaker 1: which which approach fit's it's your biology and your goals
- 3:57Speaker 1: as well as you know what what's what's given the
- 4:01Speaker 1: best best results. A lot of people are talking about this.
- 4:04Speaker 1: It's an oral goo p one, no injections required, and
- 4:09Speaker 1: I think that's really attractive.
- 4:11Speaker 2: For a lot of people.
- 4:12Speaker 1: Obviously, you know a lot of the peptides that we utilize,
- 4:16Speaker 1: most of them are injectibles. There's a few capsules that
- 4:19Speaker 1: were confident in their outcomes and results.
- 4:23Speaker 2: But you know, your your digestive system.
- 4:25Speaker 1: Taking that in and being able to utilize it metabolically
- 4:29Speaker 1: as you showed to have its challenges, but still, you know,
- 4:34Speaker 1: we've seen some results. It's a little more mixed based
- 4:38Speaker 1: on what we see in the gut, and so that's
- 4:41Speaker 1: that's probably one thing I would I would caution as
- 4:44Speaker 1: we're going through all this the research studies, I haven't
- 4:48Speaker 1: seen anything that shows like they ran a really comprehensive
- 4:51Speaker 1: digestive panel on the research candidates, but I would imagine
- 4:57Speaker 1: that has a lot to do with how affect active
- 5:00Speaker 1: some of these oral would react. And then you have retitruetide,
- 5:04Speaker 1: which is triple agonist, meaning it's you have your GLP one,
- 5:09Speaker 1: which is your glucagon like peptide or glucose like peptide.
- 5:13Speaker 2: And then you have.
- 5:14Speaker 1: GIP which that's g IP and GLP one that's turzepetide.
- 5:20Speaker 1: And then with retitrue tide, they added a glucagon piece
- 5:23Speaker 1: to it, and so really designed to target metatabolism very aggressively,
- 5:30Speaker 1: and glucagon adds like helps with the reducing that muscle
- 5:36Speaker 1: wasting that a lot of the negative side effects of
- 5:39Speaker 1: the prior GLP ones had shown. So they're both aiming
- 5:43Speaker 1: to improve weight, blood sugar, cardio metabolic health.
- 5:48Speaker 2: So you know they're both similar goals.
- 5:51Speaker 1: What makes or for lepron different it's a small molecule,
- 5:55Speaker 1: not a peptide, which this is taken once daily without
- 5:59Speaker 1: fasting requirements. It's designed to activate those same gop one
- 6:03Speaker 1: pathways as the injectable meds, and so you know.
- 6:08Speaker 2: Similar effects.
- 6:09Speaker 1: Small molecule which from a peptide's small chain of amino
- 6:15Speaker 1: acids versus just smaller, smaller molecule. And then what makes
- 6:22Speaker 1: retitrudetade different. This is activating the three receptors instead of
- 6:26Speaker 1: just the one. It's designed to influence the appetite energy
- 6:30Speaker 1: regulations simultaneously, and so you're utilizing glucose more and more
- 6:35Speaker 1: efficiently as well as boosting that metabolism, lowering the food
- 6:41Speaker 1: intake like that satiation you get satiated faster. That's similar.
- 6:47Speaker 1: With the fog Lepron still in its investigational phases, not
- 6:53Speaker 1: yet FDA approved drug, which I don't even know what
- 6:57Speaker 1: they'll be calling it once it hits the big market.
- 7:00Speaker 1: That's an Eli Lilly drug or product. So interested to
- 7:04Speaker 1: see that. I'm sure it's published somewhere. I just haven't
- 7:08Speaker 1: haven't seen it, and so you know, there's the convenience
- 7:12Speaker 1: factor with or fogula people really like I'm sure you
- 7:15Speaker 1: guys would agree sometimes in doing the daily or weekly
- 7:19Speaker 1: injections aren't the most comfortable things. I don't know, I've
- 7:23Speaker 1: gotten used to them. I don't mind the injections, but
- 7:26Speaker 1: I know it's it is one of those things that's
- 7:29Speaker 1: a little more challenging than swallowing a pill. And there's
- 7:32Speaker 1: no fasting window before you take the medication. And then
- 7:35Speaker 1: the simplicity, you know, the thought is is it makes
- 7:39Speaker 1: it easier for a patient compliance you take the capsule,
- 7:43Speaker 1: that's a lot easier than doing an injection. So you know,
- 7:48Speaker 1: with read a true TAD, you're activating three different receptors
- 7:52Speaker 1: instead of just one versus or for more focus just
- 7:55Speaker 1: on that GLP one And it had a question on
- 7:59Speaker 1: is there supposed to be a asting window now? So,
- 8:02Speaker 1: like ideally with most your peptides, specifically the growth hormone
- 8:07Speaker 1: releasing peptides, definitely want to take it ninety minutes away
- 8:11Speaker 1: from food, so like before and after, that's that's the ideal.
- 8:15Speaker 1: You know, thirty sixty minutes still good. It just reduces
- 8:20Speaker 1: the GHRP response there, but you know, and then similar
- 8:26Speaker 1: to with with true tide or the GLP ones, we
- 8:31Speaker 1: usually recommend doing it fasting. I'll say from personal experience,
- 8:37Speaker 1: I don't necessarily like regulate that super closely. Still get
- 8:42Speaker 1: similar responses. Yeah, and usually usually Dana, they'll they'll will
- 8:47Speaker 1: have it on the script of like take away from
- 8:51Speaker 1: food or things. But yeah, if you haven't seen that
- 8:54Speaker 1: on the script, maybe may we may need to make
- 8:57Speaker 1: sure that's updated. And then euretitrue tide. It's designed to
- 9:01Speaker 1: influence the appetite. So let's talk about.
- 9:05Speaker 2: Them head to head.
- 9:05Speaker 1: So you know, or full or forglepron has shown to
- 9:10Speaker 1: outperform oral semic glue tide in large phase three study greater.
- 9:14Speaker 2: Reductions in your A one C and body weight.
- 9:18Speaker 1: And then the benefits appeared early during the treatment, so
- 9:22Speaker 1: they're seeing.
- 9:23Speaker 2: Results pretty quickly or fro over.
- 9:26Speaker 1: The prown a lot more productive than just the oral
- 9:30Speaker 1: semic glue tide. I do believe it's it's a attacking
- 9:35Speaker 1: kind of multiple pathways, not just the GLP. Let's let's
- 9:41Speaker 1: dive in a little deeper there, just to fact check
- 9:43Speaker 1: me and I agree. Who names these drugs was a
- 9:47Speaker 1: comment that just came in. And I don't know who
- 9:50Speaker 1: comes up with these names. I think they just want
- 9:54Speaker 1: to create some tongue twisters, so we have to say
- 9:56Speaker 1: it so many times and it gets stuck in our head.
- 9:58Speaker 2: Maybe no idea.
- 10:00Speaker 1: I'm sure there's big Farman's got all sorts of funny
- 10:04Speaker 1: ways of doing their marketing. So why why you're at
- 10:08Speaker 1: a truetad is creating so much buzz. So it's in
- 10:12Speaker 1: its early studies showing really like substantial weight loss potential,
- 10:17Speaker 1: significantly more than some of the other GLPS improvement scene
- 10:21Speaker 1: in blood sugar, cardio metabolic markers as well, and they're
- 10:26Speaker 1: they're viewing it as like this is the next generation,
- 10:29Speaker 1: This is going to be the next big blockbluster. And
- 10:32Speaker 1: I know the reason they're eli Lilly is really taking
- 10:35Speaker 1: its time with these clinical trials, not just looking at
- 10:39Speaker 1: a weight loss, not just looking at blood sugar improvement.
- 10:43Speaker 1: They're looking at cardio metabolic so like cardiac markers, they're
- 10:48Speaker 1: looking at even like osteoarthritis and some some treatment factors there,
- 10:55Speaker 1: just because you know, blood sugars really impact arthritis. And
- 11:02Speaker 1: I think you know what it seems like is they're
- 11:06Speaker 1: trying to hit every possible condition that this this drug
- 11:11Speaker 1: could be utilized as just to you know, they can
- 11:15Speaker 1: kind of corner their market of being able to say, hey,
- 11:18Speaker 1: this is what this drugs used for, and off label
- 11:21Speaker 1: use is going to be a lot more difficult to utilize,
- 11:24Speaker 1: so they can essentially, you know, have get as many
- 11:28Speaker 1: as much use out of their drug as possible. If
- 11:31Speaker 1: you look beyond the scale or the weight loss, that's
- 11:34Speaker 1: that's just kind of one measurement of the metabolic health.
- 11:38Speaker 1: Are also the researchers in these clinical trials, they're looking
- 11:42Speaker 1: at tracking blood sugar, inflammation, lipid markers and showing you
- 11:48Speaker 1: know that that success and you know, we've we've agreed
- 11:53Speaker 1: with this all along. That weight loss is you know,
- 11:57Speaker 1: just one factor of a really healthy regiment and you
- 12:00Speaker 1: want to look at everything altogether with you know, similar
- 12:04Speaker 1: to how these researchers are looking at it. As you know,
- 12:07Speaker 1: see how blood sugars reacting, inflammation, lipid markers. It's it's
- 12:12Speaker 1: pretty cool to see. I talked to someone in the
- 12:16Speaker 1: CGM space, that's the continuous glucose monitoring space, which you
- 12:22Speaker 1: were looking at getting those into your hands a lot
- 12:26Speaker 1: easier in the future.
- 12:28Speaker 2: But you can eat like.
- 12:30Speaker 1: A meal that typically spikes blood sugars pretty significantly. When
- 12:36Speaker 1: on red a true tide, this individual noticed like his
- 12:40Speaker 1: spike was very minimal, and I think he reported his
- 12:44Speaker 1: spike when he'd take a certain meal, he was seeing
- 12:48Speaker 1: about twenty like fifty points on his blood gluecose versus
- 12:53Speaker 1: when he was on red a true tade, he only
- 12:55Speaker 1: saw it bump up about fifteen to twenty points, which
- 12:58Speaker 1: that's pretty that's a significant marker when you're looking at
- 13:02Speaker 1: like what blood sugar levels create in the body. When
- 13:07Speaker 1: you have elevated blood sugars, you're just creating a whole
- 13:10Speaker 1: host of inflammatory response. And so you know as you eat,
- 13:15Speaker 1: especially if you eat like a high fruit toose mill
- 13:17Speaker 1: if you got a lot of sugars in there, a
- 13:19Speaker 1: lot of carbohydrates that convert into increase glucose in the
- 13:25Speaker 1: in the body that can create inflammation. So if we
- 13:28Speaker 1: can keep those levels, you know, at healthy normal levels
- 13:32Speaker 1: as much as possible, that increases your metabolic crate, that
- 13:36Speaker 1: that decreases inflammation and just creates a more healthy environment.
- 13:40Speaker 1: So those are some key factors, and so some things
- 13:45Speaker 1: that you should be considering to measure so no, and
- 13:49Speaker 1: your your baseline metabolic numbers, your gluecose levels, your A
- 13:53Speaker 1: one C tracking your body composition so kind of your
- 13:57Speaker 1: fat percentages. And there's a few different ways you can
- 14:01Speaker 1: do that from home. I actually I have the Hume scale.
- 14:05Speaker 1: I think it's h u M. That's been a pretty
- 14:09Speaker 1: pretty good one you have. There's a few other ones
- 14:12Speaker 1: that a lot of gyms will have. Obviously, the prime
- 14:16Speaker 1: like the best measurement would be a Dexas scan, but
- 14:20Speaker 1: you know, not all of us can have one of those.
- 14:22Speaker 1: You know, I think they're hundreds of thousands of dollars
- 14:25Speaker 1: just implanted in our home. But if you can get
- 14:30Speaker 1: measure that body composition over time through through some of
- 14:33Speaker 1: those measurements can be really helpful. And then you know,
- 14:37Speaker 1: quarterly or every even monthly you can get a Dexa
- 14:41Speaker 1: scan and see like exactly how things are going. But
- 14:46Speaker 1: you know, at least every three to six months is
- 14:49Speaker 1: really helpful. So you know, both of these or fro
- 14:54Speaker 1: golebron as well as a true tide, they've been they've
- 14:58Speaker 1: shown they can both cause some some gi side effects.
- 15:03Speaker 2: You know, the challenge.
- 15:05Speaker 1: Especially getting into these g lp ones is your your
- 15:10Speaker 1: motility slows down, so you're you're eating less with that
- 15:15Speaker 1: as well as some of those peptizes just slow down
- 15:18Speaker 1: the movement of your bowels and so you know, that's
- 15:22Speaker 1: that's something you definitely got to pay attention to. And
- 15:25Speaker 1: that's why you know, being on you know, one of
- 15:29Speaker 1: these glp's just consistently all the time at high doses
- 15:34Speaker 1: is probably that would not be our recommendation. Microdose small
- 15:38Speaker 1: pulses cycling on and off, you know throughout is can
- 15:43Speaker 1: you know that that's what we've seen to be the
- 15:45Speaker 1: most effective to reduce some of those GI side effects.
- 15:49Speaker 1: Everyone responds kind of differently obviously, and then lifestyle is
- 15:54Speaker 1: still a big factor.
- 15:56Speaker 2: What what I love about the.
- 15:59Speaker 1: Some of these gl piece specifically like turzepetide ret true
- 16:02Speaker 1: tide I have not tried or for myself, but you
- 16:07Speaker 1: know what's nice about them is the lifestyle piece makes
- 16:12Speaker 1: it easier to implement those, especially from an eating habits
- 16:16Speaker 1: side of things. So if you're taking these, making sure
- 16:19Speaker 1: you're make sure you're getting the adequate amounts of good
- 16:22Speaker 1: quality proteins. That's probably the number one foundation is if
- 16:26Speaker 1: you're getting enough protein protein that's your building blocks for muscle.
- 16:30Speaker 1: And if you know you're on one of these GLP
- 16:33Speaker 1: ones and all you're doing is eating a bunch of
- 16:36Speaker 1: carbs and sugars, yes, your body can handle that better
- 16:40Speaker 1: being on those peptides, but it's still going to create
- 16:42Speaker 1: some metabolic deficiencies. And you know, like foods are you know,
- 16:49Speaker 1: really a big factor as well as you know, working out,
- 16:52Speaker 1: having the right good exercise regimen. Those are all still
- 16:56Speaker 1: very critical while you're on these. So the question you're
- 16:59Speaker 1: probably asking is which one's better? Which ones should you
- 17:04Speaker 1: go after? And I can't tell you that with certainty,
- 17:08Speaker 1: but I think everyone's a little different.
- 17:10Speaker 2: Or for the PROWN that's going to.
- 17:12Speaker 1: Win on ease of use and convenience. Taking a single
- 17:16Speaker 1: capsule versus the injectible, you know it definitely one's there
- 17:21Speaker 1: rede a true tide. They are seeing in these clinical
- 17:24Speaker 1: trials greater metabolic potential, So it's activating the metabolism better,
- 17:31Speaker 1: more weight loss, and just just a little a little.
- 17:35Speaker 2: More potential there.
- 17:36Speaker 1: And I think we'll probably continue to see that with
- 17:39Speaker 1: any of these injectibles. They're they're going to be more effective,
- 17:43Speaker 1: and I think the way reddit true tide's attacking each
- 17:46Speaker 1: of those three different peptides.
- 17:50Speaker 2: Is you know, just phenomenal.
- 17:53Speaker 1: So the best choice really depends on what your health
- 17:57Speaker 1: status is, your goals, what you're trying to accomplish, and
- 18:01Speaker 1: then also your preference. Dude, do you mind doing the
- 18:04Speaker 1: injectables or do you prefer the oral And so if
- 18:08Speaker 1: you're looking at kind of big picture your future self,
- 18:12Speaker 1: you know, if you're focused on improving you know, your
- 18:15Speaker 1: metabolic health and not just chasing the trends, the biggest
- 18:20Speaker 1: factor would be is know your data, know your numbers,
- 18:23Speaker 1: get regular blood work so you can know exactly where
- 18:27Speaker 1: things stand there, track your your body fat percentages and
- 18:32Speaker 1: things you know, and you can start looking at does
- 18:35Speaker 1: it makes makes sense to get a GGM, a continuous
- 18:39Speaker 1: glucose monitor. That's there's there's a few different groups out there.
- 18:44Speaker 1: We're actually working with us Stello to to get access
- 18:48Speaker 1: to our patients a little easier and tie it into
- 18:52Speaker 1: our new tech platform. Hopefully, if you're one of our clients,
- 18:56Speaker 1: you've started experiencing some of our virtual visits through our
- 19:00Speaker 1: new platform, and then we'll have a new portal rolling
- 19:03Speaker 1: out in the next week.
- 19:04Speaker 2: That well, I think you'll really like it. You can
- 19:07Speaker 2: pull in all your wearable.
- 19:09Speaker 1: Data and you can share that with us as well
- 19:13Speaker 1: as have a really fun robust dashboard that's going to
- 19:16Speaker 1: show you where things are trending and what to look
- 19:20Speaker 1: for and look out for and everything. So that is
- 19:25Speaker 1: some things to consider and yeah, hopefully this was this
- 19:29Speaker 1: was helpful.
- 19:30Speaker 2: I didn't necessarily.
- 19:31Speaker 1: Say, hey, you should go get or Ford Lebron, or
- 19:34Speaker 1: you should go get read a true TAD And obviously
- 19:36Speaker 1: that would be between you and your your physician or
- 19:38Speaker 1: whoever you're working with on the team. But I think
- 19:42Speaker 1: it's fascinating to look at some of this recent data
- 19:47Speaker 1: and research that's coming out about these new metabolic drugs
- 19:52Speaker 1: that have really transformed you know, weight loss, metabolic health,
- 19:59Speaker 1: and I think we can we'll start to see more
- 20:02Speaker 1: and more visibility around that with you know, we've had
- 20:05Speaker 1: an obesity epidemic with our younger generations, with you know,
- 20:11Speaker 1: with age, you know, comes metabolic deficiencies, and so it's
- 20:17Speaker 1: it's really exciting to see all these new new innovations
- 20:22Speaker 1: with peptides and the safety and the there's really limited
- 20:29Speaker 1: downsides and just a lot of potential upsides there. So
- 20:33Speaker 1: hopefully this is helpful fun Thank you guys for joining live.
- 20:37Speaker 1: We'll be back same time, same place next week and
- 20:41Speaker 1: appreciate you guys.
- 20:42Speaker 2: Have a great rest of your day.